Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Brouqui

Showing results (251-260 of 264) with videos related to

Pageof 27
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 27, 2020
Outbreak of pneumococcal pneumonia among shipyard workers in Marseille, France, January to February 2020Nadim Cassir, Laurence Pascal, David Ferrieux, et al.
Journal of Medical Virology|May 26, 2018
Emergence of uncommon HIV-1 non-B subtypes and circulating recombinant forms and trends in transmission of antiretroviral drug resistance in patients with primary infection during the 2013-2015 period in Marseille, Southeastern FranceCatherine Tamalet, Hervé Tissot-Dupont, Anne Motte, et al.
Expert Review of Clinical Immunology|December 28, 2020
Natural history of COVID-19 and therapeutic optionsPhilippe Gautret, Matthieu Million, Pierre-André Jarrot, et al.
International Journal of Antimicrobial Agents|December 27, 2024
Retraction notice to "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial" [International Journal of Antimicrobial Agents 56 (2020), 105949]Philippe Gautret, Jean-Christophe Lagier, Philippe Parola, et al.
International Journal of Antimicrobial Agents|March 25, 2020
RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trialPhilippe Gautret, Jean-Christophe Lagier, Philippe Parola, et al.
The Lancet. Infectious Diseases|April 3, 2016
Non-randomised Ebola trials--lessons for optimal outbreak researchGiuseppe Ippolito, Simone Lanini, Philippe Brouqui, et al.
The Lancet. Infectious Diseases|August 2, 2015
Ebola: missed opportunities for Europe-Africa researchGiuseppe Ippolito, Simone Lanini, Philippe Brouqui, et al.
Travel Medicine and Infectious Disease|March 25, 2020
Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshotSophie Amrane, Hervé Tissot-Dupont, Barbara Doudier, et al.
The New Microbiologica|December 23, 2016
Short-term economic impact of the Zika virus outbreakDaniele Macciocchi, Simone Lanini, Francesco Vairo, et al.
Travel Medicine and Infectious Disease|June 29, 2020
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysisJean-Christophe Lagier, Matthieu Million, Philippe Gautret, et al.
Pageof 27

Showing results (251-260 of 264) with videos related to

Sort By:
Pageof 27
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 27, 2020
Outbreak of pneumococcal pneumonia among shipyard workers in Marseille, France, January to February 2020Nadim Cassir, Laurence Pascal, David Ferrieux, et al.
Journal of Medical Virology|May 26, 2018
Emergence of uncommon HIV-1 non-B subtypes and circulating recombinant forms and trends in transmission of antiretroviral drug resistance in patients with primary infection during the 2013-2015 period in Marseille, Southeastern FranceCatherine Tamalet, Hervé Tissot-Dupont, Anne Motte, et al.
Expert Review of Clinical Immunology|December 28, 2020
Natural history of COVID-19 and therapeutic optionsPhilippe Gautret, Matthieu Million, Pierre-André Jarrot, et al.
International Journal of Antimicrobial Agents|December 27, 2024
Retraction notice to "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial" [International Journal of Antimicrobial Agents 56 (2020), 105949]Philippe Gautret, Jean-Christophe Lagier, Philippe Parola, et al.
International Journal of Antimicrobial Agents|March 25, 2020
RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trialPhilippe Gautret, Jean-Christophe Lagier, Philippe Parola, et al.
The Lancet. Infectious Diseases|April 3, 2016
Non-randomised Ebola trials--lessons for optimal outbreak researchGiuseppe Ippolito, Simone Lanini, Philippe Brouqui, et al.
The Lancet. Infectious Diseases|August 2, 2015
Ebola: missed opportunities for Europe-Africa researchGiuseppe Ippolito, Simone Lanini, Philippe Brouqui, et al.
Travel Medicine and Infectious Disease|March 25, 2020
Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshotSophie Amrane, Hervé Tissot-Dupont, Barbara Doudier, et al.
The New Microbiologica|December 23, 2016
Short-term economic impact of the Zika virus outbreakDaniele Macciocchi, Simone Lanini, Francesco Vairo, et al.
Travel Medicine and Infectious Disease|June 29, 2020
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysisJean-Christophe Lagier, Matthieu Million, Philippe Gautret, et al.
Pageof 27